Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Zimmer Biomet Holdings ( (ZBH) ) has shared an announcement.
On September 4, 2025, Zimmer Biomet Holdings issued two series of senior unsecured debt securities in Swiss francs, totaling CHF 600 million. These bonds, maturing in 2030 and 2035, feature interest rates of 0.930% and 1.560% respectively, and include provisions for redemption and repurchase under certain conditions, impacting the company’s financial strategy and stakeholder interests.
The most recent analyst rating on (ZBH) stock is a Buy with a $120.00 price target. To see the full list of analyst forecasts on Zimmer Biomet Holdings stock, see the ZBH Stock Forecast page.
Spark’s Take on ZBH Stock
According to Spark, TipRanks’ AI Analyst, ZBH is a Outperform.
Zimmer Biomet Holdings demonstrates strong financial performance and positive technical indicators, supported by a favorable earnings call and strategic corporate events. While the valuation suggests potential overvaluation, the company’s growth prospects and strategic initiatives provide a solid foundation for future performance.
To see Spark’s full report on ZBH stock, click here.
More about Zimmer Biomet Holdings
Zimmer Biomet Holdings, Inc. is a company operating in the medical device industry, primarily focusing on the development and manufacturing of orthopedic products and solutions.
Average Trading Volume: 1,764,086
Technical Sentiment Signal: Hold
Current Market Cap: $20.8B
See more data about ZBH stock on TipRanks’ Stock Analysis page.